Institutional Ownership Allogene Therapeutics, Inc. (ALLO)
This table provides information about the institutional ownership of Allogene Therapeutics, Inc. (ALLO). We have compiled data on the 162 institutions that hold shares in the stock, with a total of 134 Million shares, which have been reported (via 13F filing form) to have a value of $282 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Farther Finance Advisors, LLC
San Francisco, CA |
Oct 28, 2024 Q3 2024 |
160
shares
|
$353
0.0% of portfolio
|
Q2 2024
Reduced 38.93%
|
|
|
Parkside Financial Bank & Trust
|
Nov 07, 2024 Q3 2024 |
159
shares
|
$351
0.0% of portfolio
|
Q1 2021
New holding
|
|
|
West Oak Capital, LLC
|
Oct 17, 2024 Q3 2024 |
100
shares
|
$221
0.0% of portfolio
|
Q4 2021
New holding
|
|
|
Lazard Asset Management LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
96
shares
|
$212
0.0% of portfolio
|
Q3 2024
Reduced 62.5%
|
|
|
Capital Performance Advisors LLP
|
Nov 01, 2024 Q3 2024 |
41
shares
|
$90
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Covestor LTD
Boston, MA |
Nov 01, 2024 Q3 2024 |
18
shares
|
$39
0.0% of portfolio
|
Q3 2024
Reduced 5.26%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|